{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:44:34Z","timestamp":1783608274017,"version":"3.55.0"},"reference-count":18,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1001\/jamainternmed.2018.4282","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T16:35:00Z","timestamp":1535042100000},"page":"1293","source":"Crossref","is-referenced-by-count":7,"title":["Cervical Cancer Screening\u2014Moving From the Value of Evidence to the Evidence of Value"],"prefix":"10.1001","volume":"178","author":[{"given":"George F.","family":"Sawaya","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco"},{"name":"Department of Epidemiology & Biostatistics, University of California, San Francisco"},{"name":"Center for Healthcare Value, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9","key":"ied180014r2","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/jnci\/dji115","article-title":"Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.","volume":"97","author":"Leyden","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"ied180014r3","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement","author":"US Preventive Services Task Force","journal-title":"JAMA"},{"key":"ied180014r4","article-title":"Screening for cervical cancer in primary care: a decision analysis for the US Preventive Services Task Force","author":"Kim","journal-title":"JAMA"},{"key":"ied180014r5","article-title":"Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US Preventive Services Task Force","author":"Melnikow","journal-title":"JAMA"},{"issue":"2","key":"ied180014r7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ygyno.2014.12.022","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.","volume":"136","author":"Huh","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"4","key":"ied180014r8","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/AOG.0000000000001699","article-title":"Practice bulletin No. 168 summary: cervical cancer screening and prevention.","volume":"128","author":"Practice Bulletin No","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"5","key":"ied180014r9","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/AOG.0b013e318277c92a","article-title":"ACOG practice bulletin number 131: screening for cervical cancer.","volume":"120","author":"Committee on Practice Bulletins\u2014Gynecology","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"3","key":"ied180014r10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3322\/caac.v62:3","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"ied180014r11","doi-asserted-by":"publisher","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"issue":"7","key":"ied180014r12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.7326\/0003-4819-148-7-200804010-00013","article-title":"Adding human papillomavirus testing to cytology for primary cervical cancer screening: shooting first and asking questions later.","volume":"148","author":"Sawaya","year":"2008","journal-title":"Ann Intern Med"},{"issue":"1","key":"ied180014r13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jama.2018.7464","article-title":"Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial.","volume":"320","author":"Ogilvie","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"ied180014r14","doi-asserted-by":"publisher","first-page":"46.e1","DOI":"10.1016\/j.ajog.2011.07.024","article-title":"The ATHENA human papillomavirus study: design, methods, and baseline results.","volume":"206","author":"Wright","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"ied180014r15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/LGT.0b013e31829c97d8","article-title":"The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance.","volume":"18","author":"Sharp","year":"2014","journal-title":"J Low Genit Tract Dis"},{"issue":"24","key":"ied180014r16","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1001\/jama.2018.6072","article-title":"QALYs in 2018\u2014advantages and concerns.","volume":"319","author":"Neumann","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"ied180014r17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.","volume":"164","author":"Siu","year":"2016","journal-title":"Ann Intern Med"},{"issue":"22","key":"ied180014r18","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1161\/CIR.0000000000000042","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.","volume":"129","author":"Anderson","year":"2014","journal-title":"Circulation"},{"key":"ied180014r1","unstructured":"American Cancer Society. Cancer Facts & Figures 2018. Atlanta: American Cancer Society; 2018. https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2018\/cancer-facts-and-figures-2018.pdf. Accessed August 3, 2018."},{"key":"ied180014r6","unstructured":"US Preventive Services Task Force. Draft recommendation statement on cervical cancer screening. https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/draft-recommendation-statement\/cervical-cancer-screening2. Accessed August 3, 2018."}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2697768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T05:12:46Z","timestamp":1604812366000},"score":1,"resource":{"primary":{"URL":"http:\/\/archinte.jamanetwork.com\/article.aspx?doi=10.1001\/jamainternmed.2018.4282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2018.4282","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,1]]}}}